2/12
10:57 am
bcax
Bicara Therapeutics Inc. (NASDAQ: BCAX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.
Low
Report
Bicara Therapeutics Inc. (NASDAQ: BCAX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.
2/12
10:57 am
bcax
Bicara Therapeutics Inc. (NASDAQ: BCAX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.
Low
Report
Bicara Therapeutics Inc. (NASDAQ: BCAX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.
2/12
10:55 am
bcax
Rating for BCAX
Low
Report
Rating for BCAX
2/12
10:55 am
bcax
Rating for BCAX
Low
Report
Rating for BCAX
2/7
06:17 am
bcax
Bicara Therapeutics Inc. (NASDAQ: BCAX) was upgraded by analysts at Wedbush to a "strong-buy" rating.
Medium
Report
Bicara Therapeutics Inc. (NASDAQ: BCAX) was upgraded by analysts at Wedbush to a "strong-buy" rating.
2/7
06:17 am
bcax
Bicara Therapeutics Inc. (NASDAQ: BCAX) was upgraded by analysts at Wedbush to a "strong-buy" rating.
Medium
Report
Bicara Therapeutics Inc. (NASDAQ: BCAX) was upgraded by analysts at Wedbush to a "strong-buy" rating.
2/6
08:33 am
bcax
Rating for BCAX
Medium
Report
Rating for BCAX
2/6
08:33 am
bcax
Rating for BCAX
Medium
Report
Rating for BCAX
2/6
07:33 am
bcax
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at Wedbush. They set an "outperform" rating and a $31.00 price target on the stock.
Medium
Report
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at Wedbush. They set an "outperform" rating and a $31.00 price target on the stock.
2/6
07:33 am
bcax
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at Wedbush. They set an "outperform" rating and a $31.00 price target on the stock.
Medium
Report
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at Wedbush. They set an "outperform" rating and a $31.00 price target on the stock.
12/6
08:08 am
bcax
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $42.00 price target on the stock.
High
Report
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $42.00 price target on the stock.